NFKB1 and COVID-19: Evidence from pediatric COVID-19 patients has indicated overexpression of NF-κB signaling under hyperinflammatory and hypoxic conditions, corroborated by transcriptomic analyses that show significantly elevated NF-κB activity in COVID-19 tissues [13].